Funding for high-risk multi-center therapeutic clinical trials (U01) from NIDDK in diabetes, digestive, and kidney diseases
NIDDK invites investigator-initiated U01 applications for hypothesis-driven, high-risk, multi-center therapeutic clinical trials on diabetes, digestive/nutritional/obesity, kidney, urologic, or hematologic diseases. Trials must test clinical safety, tolerability, efficacy or effectiveness (not mechanistic or observational), include a complete protocol at submission, and plan for diverse U.S. r…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers